Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patients

A. Jurczyszyn, M. Olszewska-Szopa, V. Hungria, E. Crusoe, T. Pika, M. Delforge, X. Leleu, L. Rasche, AK. Nooka, A. Druzd-Sitek, J. Walewski, J. Davila, J. Caers, V. Maisnar, M. Gertz, M. Gentile, D. Fantl, G. Mele, DH. Vesole, AJ. Yee, C....

. 2016 ; 57 (9) : 2071-6. [pub] 20160104

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc18011313

Skin infiltration in multiple myeloma (skin MM) is a rare clinical problem. Only a few cases of skin involvement have been reported, primarily in single case reports. We analyzed and present the clinical outcomes, immunohistochemistry and cytogenetic features, and relevant laboratory data on 53 biopsy-proven skin MM cases. The median time from MM diagnosis to skin involvement was 2 years. There appears to be an overrepresentation of immunoglobulin class A (IgA) and light chain disease in skin MM. We found no correlation between CD56 negative MM and skin infiltration. We found that skin MM patients presented in all MM stages (i.e. ISS stages I to III), and there was no preferential cytogenetic abnormality. Patients with skin MM carry a very poor prognosis with a median overall survival (OS) of 8.5 months as time from skin involvement. Moreover, patients with IgA disease and plasmablastic morphology appear to have a worse OS.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18011313
003      
CZ-PrNML
005      
20180416095046.0
007      
ta
008      
180404s2016 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.3109/10428194.2015.1128542 $2 doi
035    __
$a (PubMed)26726867
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Jurczyszyn, Artur $u a Jagiellonian University Medical College , Cracow , Poland ;
245    10
$a Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patients / $c A. Jurczyszyn, M. Olszewska-Szopa, V. Hungria, E. Crusoe, T. Pika, M. Delforge, X. Leleu, L. Rasche, AK. Nooka, A. Druzd-Sitek, J. Walewski, J. Davila, J. Caers, V. Maisnar, M. Gertz, M. Gentile, D. Fantl, G. Mele, DH. Vesole, AJ. Yee, C. Shustik, S. Lentzsch, S. Zweegman, A. Gozzetti, AB. Skotnicki, JJ. Castillo,
520    9_
$a Skin infiltration in multiple myeloma (skin MM) is a rare clinical problem. Only a few cases of skin involvement have been reported, primarily in single case reports. We analyzed and present the clinical outcomes, immunohistochemistry and cytogenetic features, and relevant laboratory data on 53 biopsy-proven skin MM cases. The median time from MM diagnosis to skin involvement was 2 years. There appears to be an overrepresentation of immunoglobulin class A (IgA) and light chain disease in skin MM. We found no correlation between CD56 negative MM and skin infiltration. We found that skin MM patients presented in all MM stages (i.e. ISS stages I to III), and there was no preferential cytogenetic abnormality. Patients with skin MM carry a very poor prognosis with a median overall survival (OS) of 8.5 months as time from skin involvement. Moreover, patients with IgA disease and plasmablastic morphology appear to have a worse OS.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a biologické markery $7 D015415
650    _2
$a kombinovaná terapie $7 D003131
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a Kaplanův-Meierův odhad $7 D053208
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a mnohočetný myelom $x diagnóza $x mortalita $x terapie $7 D009101
650    _2
$a invazivní růst nádoru $7 D009361
650    _2
$a staging nádorů $7 D009367
650    _2
$a nádory kůže $x diagnóza $x mortalita $x terapie $7 D012878
650    _2
$a translokace genetická $7 D014178
650    _2
$a výsledek terapie $7 D016896
655    _2
$a časopisecké články $7 D016428
700    1_
$a Olszewska-Szopa, Magdalena $u b Wroclaw Medical University , Wroclaw , Poland ;
700    1_
$a Hungria, Vania $u c Santa Casa Medical School , Sao Paulo , Brazil ;
700    1_
$a Crusoe, Edvan $u c Santa Casa Medical School , Sao Paulo , Brazil ;
700    1_
$a Pika, Tomas $u d University Hospital Olomouc , Olomouc , Czech Republic ;
700    1_
$a Delforge, Michel $u e Department of Hematology University Hospitals Leuven , Belgium ;
700    1_
$a Leleu, Xavier $u f Hopital La Miletrie, CHU Poitiers , France ;
700    1_
$a Rasche, Leo $u g Department of Internal Medicine II , University Hospital Wuerzburg , Wuerzburg , Germany ;
700    1_
$a Nooka, Ajay K $u h Winship Cancer Institute, Emory University , Atlanta , GA , USA ;
700    1_
$a Druzd-Sitek, Agnieszka $u i Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology , Warsaw , Poland ;
700    1_
$a Walewski, Jan $u i Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology , Warsaw , Poland ;
700    1_
$a Davila, Julio $u j Hospital Universitario De Salamanca , Salamanca , Spain ;
700    1_
$a Caers, Jo $u k Centre Hospitalier Universitaire De Liege , Liege , Belgium ;
700    1_
$a Maisnar, Vladimir $u l Department of Medicine - Haematology , Hradec Kralove , Czech Republic ;
700    1_
$a Gertz, Morie $u m Division of Hematology , Mayo Clinic , Rochester , MN , USA ;
700    1_
$a Gentile, Massimo $u n Hematology Unit, Department of Onco-Hematology , A.O. of Cosenza , Cosenza , Italy ;
700    1_
$a Fantl, Dorotea $u o Hospital Italiano De Buenos Aires , Buenos Aires , Argentina ;
700    1_
$a Mele, Giuseppe $u p Haematology, Ospedale A. Perrino , Brindisi , Italy ;
700    1_
$a Vesole, David H $u q John Theurer Cancer Center at Hackensack University Medical Center , Hackensack , NJ , USA ;
700    1_
$a Yee, Andrew J $u r Massachusetts General Hospital Cancer Center , Harvard Medical School , Boston , MA , USA ;
700    1_
$a Shustik, Chaim $u s Royal Victoria Hospital, McGill University , Montreal , Canada ;
700    1_
$a Lentzsch, Suzanne $u t Columbia University Medical Center , New York , NY , USA ;
700    1_
$a Zweegman, Sonja $u u VU University Medical Center , Amsterdam , the Netherlands ;
700    1_
$a Gozzetti, Alessandro $u v Azienda Ospedaliera Universitaria Senese , Siena , Italy ;
700    1_
$a Skotnicki, Aleksander B $u a Jagiellonian University Medical College , Cracow , Poland ;
700    1_
$a Castillo, Jorge J $u w Dana-Farber Cancer Institute, Harvard Medical School , Boston , MA , USA.
773    0_
$w MED00003140 $t Leukemia & lymphoma $x 1029-2403 $g Roč. 57, č. 9 (2016), s. 2071-6
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26726867 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180404 $b ABA008
991    __
$a 20180416095143 $b ABA008
999    __
$a ok $b bmc $g 1288798 $s 1008125
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 57 $c 9 $d 2071-6 $e 20160104 $i 1029-2403 $m Leukemia & lymphoma $n Leuk Lymphoma $x MED00003140
LZP    __
$a Pubmed-20180404
Zpět

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace